Hanall Biopharma Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hanall Biopharma Company Limited with three other
companies in this sector in South Korea:
JW Shinyak Corp
sales of 76.95 billion Korean Won [US$67.79 million]
Nutri Biotech Co Ltd
(77.52 billion Korean Won [US$68.29 million]
Celltrion Pharm Incorporated
(74.73 billion Korean Won [US$65.84 million]
of which 100%
Hanall Biopharma Company Limited reported sales of 80.02 billion Korean Won (US$70.50 million)
December of 2015.
decrease of 1.1%
versus 2014, when the company's sales were 80.88 billion Korean Won.